Impact of injection frequency on 5-year real-world visual acuity outcomes of aflibercept therapy for neovascular age-related macular degeneration.
Shruti ChandraRajna RasheedDeepthy MenonNamritha PatraoAli LaminSarega GurudasKonstantinos BalaskasPraveen J PatelNaser AliSobha SivaprasadPublished in: Eye (London, England) (2020)
Aflibercept therapy results in sustained good visual outcome over 5 years in neovascular AMD eyes when early and persistent treatment is given.